Skip to main content
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Leadership
    • Board of Directors
  • Portfolio
    • Hepatocellular Carcinoma
    • Gravitas Life Sciences
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    Hepion Pharmaceuticals
    Media Placements

    Treating NASH and Other Fatty Liver Diseases Using Drugs Developed Around Cyclophilin Inhibition with Dr. Robert Foster Hepion Pharmaceuticals [Empowered Patient Podcast]

    By AdminApril 18, 2022No Comments
    https://hepionpharma.com/wp-content/uploads/2022/04/EP220322_Hepion.mp3
    About
    Newsroom
    Investors
    Contact
    Subscribe for Updates

    © 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use

    Share
    Share Share Pin
    Close Menu
    • About
      • Leadership
      • Board of Directors
    • Portfolio
      • Hepatocellular Carcinoma
      • Gravitas Life Sciences
    • Newsroom
    • Investors
      • Investor Overview
      • Press Releases
      • Presentations
      • Stock Information
      • SEC Filings
      • Corporate Governance
    • Contact